|
SkyePharma asthma drug wins European backing
Reuters UK By Paul Sandle | LONDON (Reuters) – SkyePharma said on Friday its lead product, asthma therapy Flutiform, had been recommended for approval by European regulators, doubling the value of the group's shares. Flutiform was referred to the European … SkyePharma's asthma drug wins European backing |
View full post on asthma – Google News